{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T15:21:39Z","timestamp":1793805699115,"version":"4.6.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,1,31]],"date-time":"2015-01-31T00:00:00Z","timestamp":1422662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s12032-015-0494-1","type":"journal-article","created":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T06:20:15Z","timestamp":1422598815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Crk-like adapter protein regulates CCL19\/CCR7-mediated epithelial-to-mesenchymal transition via ERK signaling pathway in epithelial ovarian carcinomas"],"prefix":"10.1007","volume":"32","author":[{"given":"Shaomei","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangshan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,31]]},"reference":[{"key":"494_CR1","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E. Ovarian cancer development and metastasis. Am J Pathol. 2010;177:1053\u201364.","journal-title":"Am J Pathol"},{"key":"494_CR2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrclinonc.2013.5","volume":"10","author":"RL Coleman","year":"2013","unstructured":"Coleman RL, Monk BJ, Sood AK, et al. Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol. 2013;10:211\u201324.","journal-title":"Nat Rev Clin Oncol"},{"key":"494_CR3","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","volume":"164","author":"M Shih Ie","year":"2004","unstructured":"Shih Ie M, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004;164:1511\u20138.","journal-title":"Am J Pathol"},{"key":"494_CR4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/his.12033","volume":"62","author":"A Gurung","year":"2013","unstructured":"Gurung A, Hung T, Morin J, et al. Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates. Histopathology. 2013;62:59\u201370.","journal-title":"Histopathology"},{"key":"494_CR5","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1177\/1947601910397188","volume":"1","author":"G Sriram","year":"2010","unstructured":"Sriram G, Birge RB. Emerging roles for crk in human cancer. Genes Cancer. 2010;1:1132\u20139.","journal-title":"Genes Cancer"},{"key":"494_CR6","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.2217\/fon.14.199","volume":"10","author":"C Guo","year":"2014","unstructured":"Guo C, Liu S, Sun MZ. The role of CT10 regulation of kinase-like in cancer. Future Oncol. 2014;10:2687\u201397.","journal-title":"Future Oncol"},{"key":"494_CR7","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/jcb.24749","volume":"115","author":"S Kumar","year":"2014","unstructured":"Kumar S, Fajardo JE, Birge RB, et al. Crk at the quarter century mark: perspectives in signaling and cancer. J Cell Biochem. 2014;115:819\u201325.","journal-title":"J Cell Biochem"},{"key":"494_CR8","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1007\/s13277-013-1536-y","volume":"35","author":"B Han","year":"2014","unstructured":"Han B, Luan L, Xu Z, et al. Clinical significance and biological roles of CRKL in human bladder carcinoma. Tumour Biol. 2014;35:4101\u20136.","journal-title":"Tumour Biol"},{"key":"494_CR9","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.exphem.2012.08.007","volume":"40","author":"S Evren","year":"2012","unstructured":"Evren S, Ma XZ, Sakac D, et al. SHP-1 protein tyrosine phosphatase associates with the adaptor protein CrkL. Exp Hematol. 2012;40:1055\u20139.","journal-title":"Exp Hematol"},{"key":"494_CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1478-811X-7-13","volume":"7","author":"RB Birge","year":"2009","unstructured":"Birge RB, Kalodimos C, Inagaki F, et al. Crk and CrkL adaptor proteins: networks for physiological and pathological signaling. Cell Commun Signal. 2009;7:13.","journal-title":"Cell Commun Signal"},{"key":"494_CR11","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.bcp.2012.11.005","volume":"85","author":"JV Joseph","year":"2013","unstructured":"Joseph JV, Balasubramaniyan V, Walenkamp A, et al. TGF-\u03b2 as a therapeutic target in high grade gliomas promises and challenges. Biochem Pharmacol. 2013;85:478\u201385.","journal-title":"Biochem Pharmacol"},{"key":"494_CR12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2174\/138161206775201901","volume":"12","author":"W Wick","year":"2006","unstructured":"Wick W, Naumann U, Weller M. Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma. Curr Pharm Des. 2006;12:341\u20139.","journal-title":"Curr Pharm Des"},{"key":"494_CR13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJM200109133451113","volume":"345","author":"PM Murphy","year":"2001","unstructured":"Murphy PM. Chemokines and the molecular basis of cancer metastasis. New Engl J Med. 2001;345:833\u20135.","journal-title":"New Engl J Med"},{"key":"494_CR14","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1002\/eji.201242614","volume":"42","author":"GL Moschovakis","year":"2012","unstructured":"Moschovakis GL, F\u00f6rster R. Multifaceted activities of CCR7 regulate T-cell homeostasis in health and disease. Eur J Immunol. 2012;42:1949\u201355.","journal-title":"Eur J Immunol"},{"key":"494_CR15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/mic.10.3-4.325.334","volume":"10","author":"G M\u00fcller","year":"2003","unstructured":"M\u00fcller G, Lipp M. Shaping up adaptive immunity: the impact of CCR7 and CXCR5 on lymphocyte trafficking. Microcirculation. 2003;10:325\u201334.","journal-title":"Microcirculation"},{"key":"494_CR16","doi-asserted-by":"crossref","first-page":"14468","DOI":"10.1074\/jbc.271.24.14468","volume":"271","author":"M Matsuda","year":"1996","unstructured":"Matsuda M, Ota S, Tanimura R, et al. Interaction between the amino-terminal SH3 domain of CRK and its natural target proteins. J Biol Chem. 1996;271:14468\u201372.","journal-title":"J Biol Chem"},{"key":"494_CR17","first-page":"3402","volume":"9","author":"Y Ding","year":"2003","unstructured":"Ding Y, ShimadaY Maeda M, et al. Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res. 2003;9:3402\u201312.","journal-title":"Clin Cancer Res"},{"key":"494_CR18","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.3892\/ijo.2014.2674","volume":"45","author":"FY Liu","year":"2014","unstructured":"Liu FY, Safdar J, Li ZN, et al. CCR7 regulates cell migration and invasion through MAPKs in metastatic squamous cell carcinoma of head and neck. Int J Oncol. 2014;45:2502\u201310.","journal-title":"Int J Oncol"},{"key":"494_CR19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.lungcan.2014.05.018","volume":"85","author":"K Suda","year":"2014","unstructured":"Suda K, Mizuuchi H, Murakami I, et al. CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation. Lung Cancer. 2014;85:147\u201351.","journal-title":"Lung Cancer"},{"key":"494_CR20","doi-asserted-by":"crossref","first-page":"12293","DOI":"10.1007\/s13277-014-2540-6","volume":"35","author":"S Cheng","year":"2014","unstructured":"Cheng S, Han L, Guo J, et al. The essential roles of CCR7 in epithelial-to-mesenchymal transition induced by hypoxia in epithelial ovarian carcinomas. Tumour Biol. 2014;35:12293\u20138.","journal-title":"Tumour Biol"},{"key":"494_CR21","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1186\/1471-2164-15-1169","volume":"15","author":"P Nizard","year":"2014","unstructured":"Nizard P, Ezan F, Bonnier D, et al. Integrative analysis of high-throughput RNAi screen data identifies the FER and CRKL tyrosine kinases as new regulators of the mitogenic ERK-dependent pathways in transformed cells. BMC Genomics. 2014;15:1169.","journal-title":"BMC Genomics"},{"key":"494_CR22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1478-3231.2010.02205.x","volume":"30","author":"BL Copple","year":"2010","unstructured":"Copple BL. Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-beta-dependent mechanisms. Liver Int. 2010;30:669\u201382.","journal-title":"Liver Int"},{"key":"494_CR23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/annonc\/mdq292","volume":"21","author":"P Savagner","year":"2010","unstructured":"Savagner P. The epithelial-mesenchymal transition (EMT) phenomenon. Ann Oncol. 2010;21:89\u201392.","journal-title":"Ann Oncol"},{"key":"494_CR24","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell. 2009;139:871\u201390.","journal-title":"Cell"},{"key":"494_CR25","first-page":"3810","volume":"117","author":"DF Higgins","year":"2007","unstructured":"Higgins DF, Kimura K, Bernhardt WM, et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest. 2007;117:3810\u201320.","journal-title":"J Clin Invest"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-015-0494-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-015-0494-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-015-0494-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T09:48:31Z","timestamp":1566294511000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-015-0494-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,31]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["494"],"URL":"https:\/\/doi.org\/10.1007\/s12032-015-0494-1","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,31]]},"article-number":"47"}}